Russell Investments Group
PLSE icon

Russell Investments Group’s Pulse Biosciences PLSE Stock Holding History

Russell Investments Group’s Portfolio PLSE Stock Details PLSE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$232K Buy
8,360
+3,696
+79% +$87.2K ﹤0.01% 3124
2026
Q1 		$101K Sell
4,664
-442
-9% -$8.16K ﹤0.01% 3086
2025
Q4 		$70.1K Buy
5,106
+619
+14% +$9.65K ﹤0.01% 3178
2025
Q3 		$79.4K Buy
4,487
+1,372
+44% +$21.7K ﹤0.01% 3107
2025
Q2 		$47K Buy
3,115
+333
+12% +$5.53K ﹤0.01% 2997
2025
Q1 		$44.8K Sell
2,782
-46
-2% -$857 ﹤0.01% 2939
2024
Q4 		$49.2K Sell
2,828
-21
-0.7% -$370 ﹤0.01% 2832
2024
Q3 		$50K Sell
2,849
-28
-1% -$477 ﹤0.01% 2795
2024
Q2 		$32.2K Buy
2,877
+1,530
+114% +$14.4K ﹤0.01% 2859
2024
Q1 		$11.7K Sell
1,347
-56
-4% -$515 ﹤0.01% 2831
2023
Q4 		$17.2K Buy
+1,403
New +$9.71K ﹤0.01% 2762

Other funds holding PLSE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PCM
Portolan Capital Management Boston, Massachusetts $2.67B AUM 169.09% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Russell Investments Group's PLSE Position: Q2 2026 in Review

Russell Investments Group increased its Pulse Biosciences (PLSE) stake by 79% in Q2 2026, buying an estimated $87.2K and bringing the position to 8,360 shares worth $232K. The position accounts for ﹤0.01% of the portfolio, ranked #3124.

Russell Investments Group first reported a position in PLSE in Q4 2023 and has held it in 11 quarters since. 106 funds tracked by Wall St. Rank hold PLSE as of Q2 2026.

  • Russell Investments Group held 8,360 shares of Pulse Biosciences worth $232K as of Q2 2026.
  • Russell Investments Group bought 3,696 Pulse Biosciences shares in Q2 2026, an estimated $87.2K.
  • Pulse Biosciences made up ﹤0.01% of Russell Investments Group's portfolio in Q2 2026, its #3124 holding.
  • Russell Investments Group first reported a position in Pulse Biosciences in Q4 2023 and has held it in 11 quarters since.
  • 106 funds tracked by Wall St. Rank held Pulse Biosciences as of Q2 2026.

Based on Russell Investments Group's 13F filing for Q2 2026, filed 6 Aug 2026.